XML 109 R22.htm IDEA: XBRL DOCUMENT
v2.4.0.6

SEGMENT INFORMATION | 12 Months Ended
--- | ---
Mar. 30, 2013
Segment Reporting [Abstract] |
SEGMENT INFORMATION | SEGMENT INFORMATION Segment Definition Criteria We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product categories. Enterprise Wide Disclosures About Product and Services We have four global product families: plasma, blood center, hospital, and software solutions. Our products include whole blood disposables, equipment devices and the related disposables used with these devices. Disposables include part of plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals. Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients as well as disposables for manual whole blood collection. Hospital consists of surgical disposables (principally the Cell Saver® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT® cardiovascular perioperative autotransfusion system designed to remain with the patient following surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG® Thrombelastograph® hemostasis analyzer used to help assess a surgical patient’s hemostasis during and after surgery). Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency. Revenues from External Customers:
(In thousands) | March 30, 2013 |  | March 31, 2012 |  | April 2, 2011
Disposable revenues |  |  |  |  |  |  |  |
Plasma disposables | $ | 268,900 |  |  | $ | 258,061 |  |  | $ | 227,209 |
Blood center disposables |  |  |  |  |  |  |  |
Platelet | 169,602 |  |  | 167,946 |  |  | 156,251 |
Red cell | 49,733 |  |  | 48,034 |  |  | 46,828 |
Whole blood | 138,436 |  |  | — |  |  | — |
| 357,771 |  |  | 215,980 |  |  | 203,079 |
Hospital disposables |  |  |  |  |  |  |  |
Surgical | 73,508 |  |  | 66,619 |  |  | 66,503 |
OrthoPAT | 30,230 |  |  | 31,186 |  |  | 35,631 |
Diagnostics | 27,356 |  |  | 23,087 |  |  | 19,414 |
| 131,094 |  |  | 120,892 |  |  | 121,548 |
Disposables revenue | 757,765 |  |  | 594,933 |  |  | 551,836 |
Software solutions | 69,952 |  |  | 70,557 |  |  | 66,876 |
Equipment & other | 64,273 |  |  | 62,354 |  |  | 57,982 |
Total revenues | $ | 891,990 |  |  | $ | 727,844 |  |  | $ | 676,694 |
Enterprise Wide Disclosures About Product and Services Year Ended (in thousands)
March 30, 2013 | United States |  | Other North America |  | Total North America |  | Japan |  | Other Asia |  | Total Europe |  | Total Consolidated
Sales | $ | 454,874 |  |  | $ | 6,851 |  |  | $ | 461,725 |  |  | $ | 120,726 |  |  | $ | 84,860 |  |  | $ | 224,679 |  |  | $ | 891,990 |
Total Assets | $ | 830,754 |  |  | $ | 225,849 |  |  | $ | 1,056,603 |  |  | $ | 44,189 |  |  | $ | 41,037 |  |  | $ | 320,088 |  |  | $ | 1,461,917 |
Long-Lived Assets | $ | 503,606 |  |  | $ | 209,439 |  |  | $ | 713,045 |  |  | $ | 12,977 |  |  | $ | 8,076 |  |  | $ | 117,717 |  |  | $ | 851,815 |
March 31, 2012 | United States |  | Other North America |  | Total North America |  | Japan |  | Other Asia |  | Total Europe |  | Total Consolidated
Sales | $ | 352,160 |  |  | $ | 512 |  |  | $ | 352,672 |  |  | $ | 124,381 |  |  | $ | 67,223 |  |  | $ | 183,568 |  |  | $ | 727,844 |
Total Assets | $ | 634,171 |  |  | $ | 15,365 |  |  | $ | 649,536 |  |  | $ | 50,509 |  |  | $ | 27,353 |  |  | $ | 183,737 |  |  | $ | 911,135 |
Long-Lived Assets | $ | 305,370 |  |  | $ | 12,796 |  |  | $ | 318,166 |  |  | $ | 13,128 |  |  | $ | 3,961 |  |  | $ | 38,009 |  |  | $ | 373,264 |
April 2, 2011 | United States |  | Other North America |  | Total North America |  | Japan |  | Other Asia |  | Total Europe |  | Total Consolidated
Sales | $ | 316,447 |  |  | $ | 908 |  |  | $ | 317,355 |  |  | $ | 110,263 |  |  | $ | 61,594 |  |  | $ | 187,482 |  |  | $ | 676,694 |
Total Assets | $ | 582,733 |  |  | $ | 15,903 |  |  | $ | 598,636 |  |  | $ | 47,156 |  |  | $ | 18,164 |  |  | $ | 169,308 |  |  | $ | 833,264 |
Long-Lived Assets | $ | 305,305 |  |  | $ | 12,715 |  |  | $ | 318,020 |  |  | $ | 12,391 |  |  | $ | 4,181 |  |  | $ | 38,092 |  |  | $ | 372,684 |
The Long-Lived Assets reported above include Goodwill, Intangibles and Net Property, Plant and Equipment.

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration